Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression-Reference-Cited by-同舟云学术

Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression

Published:2021-09-01 Issue:7 Volume:31 Page:494-503
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

DelBello Melissa P.¹^ORCID,Tocco Michael²,Pikalov Andrei³,Deng Ling³,Goldman Robert²

Affiliation:

1. Division of Bipolar Disorders Research, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

2. Sunovion Pharmaceuticals, Inc., Marlborough, Massachusetts, USA.

3. Sunovion Pharmaceuticals, Inc., Fort Lee, New Jersey, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2021.0040

Reference43 articles.

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.

2. The predictive significance of neurocognitive factors for functional outcome in bipolar disorder

3. Course and outcome of bipolar spectrum disorder in children and adolescents: A review of the existing literature

4. Longitudinal Trajectories and Associated Baseline Predictors in Youths With Bipolar Spectrum Disorders

5. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications;European Journal of Medicinal Chemistry;2024-11

2. Advances in the management of bipolar disorder in children and adolescents: an update on the literature;Expert Review of Neurotherapeutics;2024-08-05

3. LURASIDONE;Prescriber's Guide – Children and Adolescents;2024-05-02

4. Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression;Current Neuropharmacology;2023-06

5. Lurasidone versus Quetiapine for Cognitive Impairments in Young Patients with Bipolar Depression: A Randomized, Controlled Study;Pharmaceuticals;2022-11-14